# Warren Point Capital

> Warren Point Capital is a VC fund backing Health Care and Medical Device. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Santa Barbara, United States
- Total investments: 3
- Last investment: Jan 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/warren-point-capital/
- Website: https://www.warrenpointcapital.com

Warren Point Capital is an investment firm that finds and purchases minority stakes in medical technology companies.

## Contacts

5 contacts available for Warren Point Capital. Shizune tracks 1 team members at Warren Point Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/warren-point-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 100% |
| Medical Device | 2 | 67% |
| Medical | 1 | 33% |
| Software | 1 | 33% |
| Real Time | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series D | 2 | 67% |
| Venture - Series Unknown | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| James Leech | Managing Partner | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GT Medical Technologies | GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement. | $53.3M | Series D | Jan 16, 2025 |  |
| Moximed | Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis. | $61M | Series D | Aug 13, 2024 |  |
| Human API | Human API is a real-time health data network that gives consumers a simple way to view and share their health data from everywhere - regardless of how or where that data was collected, processed, or stored. The company provides a single, secure connection to data from 90% of US hospitals, electronic medical records, pharmacies, and labs, along with300+ wearable devices and wellness apps. Consumers are in full control of what companies they share their health data with, and companies have one easy way to access fragmented health data sources.It was founded in 2013 and is based in San Mateo, California. |  | Venture - Series Unknown | Nov 01, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Gilde Healthcare](https://shizune.co/investors/profile/gilde-healthcare-partners) — VC Fund, 2 deals together
- [Accelmed](https://shizune.co/investors/profile/accelmed) — VC Fund, 1 deal together
- [Advent Life Sciences](https://shizune.co/investors/profile/advent-life) — VC Fund, 1 deal together
- [Evidity Health Capital](https://shizune.co/investors/profile/canepa-advanced-healthcare-fund) — VC Fund, 1 deal together
- [Cormorant Asset Management](https://shizune.co/investors/profile/cormorant-asset-management) — VC Fund, 1 deal together
- Elevage Medical Technologies — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund
- [Trifecta Capital Advisors](https://shizune.co/investors/profile/trifecta-capital-advisors) — VC Fund

## FAQ

### What does Warren Point Capital invest in?

Warren Point Capital invests primarily in Health Care, Medical Device and Medical startups, most often at Series D and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Warren Point Capital?

Public channels for Warren Point Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Warren Point Capital?

The team at Warren Point Capital includes James Leech (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co